H1 2024 Gene Therapy Landscape Review

Dive deep into the rapidly evolving world of gene therapy with our H1 2024 Gene Therapy Landscape Review Series. This comprehensive series provides unparalleled insights into the commercial market, drug development, trial activities, and emerging trends that are shaping the future of gene therapy. Backed by exclusive data from Beacon as of July 2nd, 2024, these reports offer critical analysis and exclusive industry insights to guide your strategic decisions.

H1 2024 Gene Therapy Landscape Review

Why You Should Download This Series:

Drug Landscape – An in-depth analysis of the gene therapy drug landscape, featuring a detailed review of Pfizer & Spark Therapeutics’ BEQVEZ, the second AAV gene therapy approved for Hemophilia B, and the latest advancements in viral and non-viral delivery systems.
Trials and Regulatory Announcements – A review of 104 new gene therapy trials initiated in 2024, a promising 24% CAGR in trial activity since 2019, and insights into 7.1% of trials that have seen status changes, including terminations, suspensions, and withdrawals. Stay informed on key regulatory announcements and their impact on the market.
Emerging Trends and Market Insights – A comprehensive review of major deals from H1 2024 and an overview of the key companies operating in the gene therapy space. Discover the latest emerging trends and how evolving partnerships are influencing innovation and market opportunities.

Why Beacon? Our series is powered by Beacon’s extensive database, offering the ability to filter and analyze over 176 unique delivery systems, 67 editing technologies, and 469 genes/mutations. Gain insights into AAV serotypes, non-viral systems, and more to benchmark your pipeline and drive confident, data-backed investment decisions.

Prepare for the future of gene therapy with the insights and data that matter. Download our H1 2024 Landscape Review Series today.

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.